| Bioactivity | SARD279 is a potent and selective Androgen Receptor degrader with DC50 value of 1099 nM. SARD279 can be used in prostate cancer research[1]. |
| CAS | 1489236-55-6 |
| Formula | C33H41F3N4O5S |
| Molar Mass | 662.76 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Salami J, et al. Androgen receptor degradation by the proteolysis-targeting chimera ARCC-4 outperforms enzalutamide in cellular models of prostate cancer drug resistance. Commun Biol. 2018 Aug 2;1:100. |
SARD279
CAS: 1489236-55-6 F: C33H41F3N4O5S W: 662.76
SARD279 is a potent and selective Androgen Receptor degrader with DC50 value of 1099 nM. SARD279 can be used in prostate
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.